Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH ##### Up next ###### [Canadian Solar Delivers Its First Grid-Connected Battery Energy Storage System in Japan](https://thailandbusinessnews.net/press-release/canadian-solar-delivers-its-first-grid-connected-battery-energy-storage-system-in-japan/) Published on 11 February 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2804420/logo_Ribolia_Logo.jpg?p=medium600 "logo")SUZHOU, China and MÖLNDAL, Sweden, Feb. 11, 2026 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today announced that they have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) ("Madrigal") for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). The collaboration will utilize Ribo’s validated liver targeting siRNA GalSTARTM platform to develop novel treatments for MASH. The license agreement covers multiple existing pre-clinical assets from Ribo. In addition, both parties have the option to expand the scope of collaboration onto new siRNA programs including bi-specific siRNAs (agents that target two disease-causing genes simultaneously) utilizing Ribo’s unique GalSTARTM and siRNA chemical modification platforms. *We are enthusiastic to join forces with Madrigal Pharmaceuticals, drawing on their extensive knowledge together with our siRNA expertise to advance life changing therapies for people affected by liver disease*, says Dr. Zicai Liang, CEO of Ribo. *To have the opportunity to work with the company that successfully launched the world’s first drug for MASH, a disease with rising prevalence and strong associations with numerous life-threatening comorbidities, is very encouraging. Leveraging our proprietary siRNA platform, we aim to expand the MASH therapeutic landscape through complementary, multi-mechanistic approaches, delivering more targeted and effective treatments for patients with unmet needs*, says Dr Li-Ming Gan CEO of Ribocure and co-CEO of Ribo. **Financial Considerations** Under the agreement, Ribo has granted Madrigal an exclusive global license to develop, manufacture, and commercialize several siRNA assets. Ribo will receive an upfront payment of US$60M and cumulative payments could reach US$4.4B if certain development, regulatory and commercial milestones are achieved, as well as potential royalties on net sales. **About MASH** Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is a serious liver disease that can progress to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. MASH is the leading cause of liver transplantation in women and the second leading cause of all liver transplantation in the U.S., and the fastest-growing indication for liver transplantation in Europe. Once patients progress to MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), the risk of adverse liver outcomes increases dramatically: these patients have a 10-17 times higher risk of liver-related mortality as compared to patients without fibrosis. Those who progress to cirrhosis face a 42 times higher risk of liver-related mortality, underscoring the need to treat MASH before complications of cirrhosis develop. MASH is also an independent driver of cardiovascular disease, the leading cause of mortality for patients. As MASH disease awareness improves and disease prevalence increases, the number of diagnosed patients with MASH with moderate to advanced fibrosis or compensated MASH cirrhosis (F2-F4c) is expected to grow. **About Suzhou Ribo Life Science Co. Ltd. and Ribocure Pharmaceuticals AB** Suzhou Ribo Life Science Co. Ltd. (HKEX: 6938) is an innovative clinical stage R&D company devoted to the development of nucleic acid drugs and related products based on the RNA interference (RNAi) technology. With its innovative R&D capabilities with vertically integrated technological platforms, Ribo has built a strong product pipeline, aiming to make contribution to the treatment of serious diseases with unmet medical needs. As a subsidiary of Suzhou Ribo Life Science, Ribocure Pharmaceuticals AB is dedicated to globalized development of life-saving oligonucleotide therapies, with focus on development of assets and pipeline as well as new target ideas and on building innovative capacities to conduct clinical trials and developing siRNA drugs to address real unmet medical needs globally. For more information, please visit [www.ribolia.com](http://www.ribolia.com/en) and [www.ribocure.com](http://www.ribocure.com/) **About Madrigal Pharmaceuticals** Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit [www.madrigalpharma.com](https://www.madrigalpharma.com/). [Source link ](http://www.prnasia.com/story/archive/4885754_AE85754_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/silchester-international-investors-press-release-and-egm-demand-letter-medipal-holdings-corporation-7459jt/) ## Silchester International Investors – Press Release and EGM Demand Letter – Medipal Holdings Corporation (7459:JT) LONDON, Sept. 2, 2026 /PRNewswire/ — Since April 2026, Silchester has had… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 2, 2026 [](https://thailandbusinessnews.net/press-release/bbsol-unveils-its-largest-airdrop-on-bybit-web3/) ![bbSOL Unveils its Largest Airdrop on Bybit Web3](https://i0.wp.com/r2.thailandbusinessnews.net/2025/01/1737993600_Logo.jpg?resize=260%2C140&ssl=1 "bbSOL Unveils its Largest Airdrop on Bybit Web3") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## bbSOL Unveils its Largest Airdrop on Bybit Web3 DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ — Bybit, the world’s second-largest crypto… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 27, 2025 [](https://thailandbusinessnews.net/press-release/cellebrite-announces-20-justys-award-winners-at-c2c-user-summit-2026/) ![Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026](https://i0.wp.com/mma.prnasia.com/media2/2855183/5915452/Cellebrite_Logo.jpg?resize=260%2C140&ssl=1 "Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Cellebrite Announces 20 JUSTYS Award Winners at C2C User Summit 2026 Hundreds gathered to recognize the best and brightest in digital investigations TYSONS… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 15, 2026 ##### Most Read - [![The Sanya EDITION Presents an Island Celebration Experience for Mid-Autumn Festival and China National Day Golden Week](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/the-sanya-edition-presents-an-island-celebration-experience-for-mid-autumn-festival-and-china-national-day-golden-week/ "The Sanya EDITION Presents an Island Celebration Experience for Mid-Autumn Festival and China National Day Golden Week") [The Sanya EDITION Presents an Island Celebration Experience for Mid-Autumn Festival and China National Day Golden Week](https://thailandbusinessnews.net/press-release/the-sanya-edition-presents-an-island-celebration-experience-for-mid-autumn-festival-and-china-national-day-golden-week/ "The Sanya EDITION Presents an Island Celebration Experience for Mid-Autumn Festival and China National Day Golden Week") - [![Chery Auto to Showcase Nearly 20 Green Technology and Ecosystem Innovations. 2026 Chery International User Summit Opens in October](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chery-auto-to-showcase-nearly-20-green-technology-and-ecosystem-innovations-2026-chery-international-user-summit-opens-in-october/ "Chery Auto to Showcase Nearly 20 Green Technology and Ecosystem Innovations. 2026 Chery International User Summit Opens in October") [Chery Auto to Showcase Nearly 20 Green Technology and Ecosystem Innovations. 2026 Chery International User Summit Opens in October](https://thailandbusinessnews.net/press-release/chery-auto-to-showcase-nearly-20-green-technology-and-ecosystem-innovations-2026-chery-international-user-summit-opens-in-october/ "Chery Auto to Showcase Nearly 20 Green Technology and Ecosystem Innovations. 2026 Chery International User Summit Opens in October") - [![Dell InnovateFest 2026 Champions Inclusive and Independent Living for Persons with Disabilities Through AI and Cloud-Native Innovation](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dell-innovatefest-2026-champions-inclusive-and-independent-living-for-persons-with-disabilities-through-ai-and-cloud-native-innovation/ "Dell InnovateFest 2026 Champions Inclusive and Independent Living for Persons with Disabilities Through AI and Cloud-Native Innovation") [Dell InnovateFest 2026 Champions Inclusive and Independent Living for Persons with Disabilities Through AI and Cloud-Native Innovation](https://thailandbusinessnews.net/press-release/dell-innovatefest-2026-champions-inclusive-and-independent-living-for-persons-with-disabilities-through-ai-and-cloud-native-innovation/ "Dell InnovateFest 2026 Champions Inclusive and Independent Living for Persons with Disabilities Through AI and Cloud-Native Innovation") - [![Hisense and Devialet Redefine Home Entertainment](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/Hisense_s_product_lines__Tuned_Devialet.jpg?fit=600%2C336&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/hisense-and-devialet-redefine-home-entertainment/ "Hisense and Devialet Redefine Home Entertainment") [Hisense and Devialet Redefine Home Entertainment](https://thailandbusinessnews.net/press-release/hisense-and-devialet-redefine-home-entertainment/ "Hisense and Devialet Redefine Home Entertainment") - [![RIMAN Brings ICD to Rustan's Makati, Expanding Its Premium K-Beauty Presence in the Philippines](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/riman-brings-icd-to-rustans-makati-expanding-its-premium-k-beauty-presence-in-the-philippines/ "RIMAN Brings ICD to Rustan's Makati, Expanding Its Premium K-Beauty Presence in the Philippines") [RIMAN Brings ICD to Rustan's Makati, Expanding Its Premium K-Beauty Presence in the Philippines](https://thailandbusinessnews.net/press-release/riman-brings-icd-to-rustans-makati-expanding-its-premium-k-beauty-presence-in-the-philippines/ "RIMAN Brings ICD to Rustan's Makati, Expanding Its Premium K-Beauty Presence in the Philippines") - [![oneworld Named World's Best Airline Alliance at the 2026 Skytrax Awards](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/oneworld-named-worlds-best-airline-alliance-at-the-2026-skytrax-awards/ "oneworld Named World's Best Airline Alliance at the 2026 Skytrax Awards") [oneworld Named World's Best Airline Alliance at the 2026 Skytrax Awards](https://thailandbusinessnews.net/press-release/oneworld-named-worlds-best-airline-alliance-at-the-2026-skytrax-awards/ "oneworld Named World's Best Airline Alliance at the 2026 Skytrax Awards") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/olight-unveils-arktac-series-and-new-arkpro-ultra-colorway-at-o-fan-day-2026/) ![Olight Unveils ArkTac Series and New ArkPro Ultra Colorway at O-Fan Day 2026](https://i0.wp.com/mmx.prnasia.com/media/MS1988633/20260915071850EDT_image_1.jpg?resize=260%2C140&ssl=1 "Olight Unveils ArkTac Series and New ArkPro Ultra Colorway at O-Fan Day 2026") ## Olight Unveils ArkTac Series and New ArkPro Ultra Colorway at O-Fan Day 2026 HOUSTON, Sept. 20, 2026 /PRNewswire/ — Olight, a global innovator in portable… [](https://thailandbusinessnews.net/press-release/insta360-opens-first-flagship-store-outside-asia-in-new-yorks-times-square-amid-global-retail-expansion/) ![Insta360 Opens First Flagship Store Outside Asia In New York's Times Square Amid Global Retail Expansion](https://i0.wp.com/mmx.prnasia.com/media/MS1992002/20260919133307EDT_image_1.jpg?resize=260%2C140&ssl=1 "Insta360 Opens First Flagship Store Outside Asia In New York's Times Square Amid Global Retail Expansion") ## Insta360 Opens First Flagship Store Outside Asia In New York's Times Square Amid Global Retail Expansion NEW YORK, Sept. 20, 2026 /PRNewswire/ — Insta360 officially opened its first… [](https://thailandbusinessnews.net/press-release/qatar-foundation-wilton-park-dialogue-calls-for-global-action-to-drive-social-development-through-sport/) ![Qatar Foundation – Wilton Park Dialogue Calls for Global Action to Drive Social Development Through Sport](https://i0.wp.com/mmx.prnasia.com/media/MS1991964/Her-Excellency-Sheikha-Hind-bint-Hamad-Al-Thani-Vice-Chairperson-of-Qatar-F.jpg?resize=260%2C140&ssl=1 "Qatar Foundation – Wilton Park Dialogue Calls for Global Action to Drive Social Development Through Sport") ## Qatar Foundation – Wilton Park Dialogue Calls for Global Action to Drive Social Development Through Sport Three-day UK dialogue emphasizes female empowerment, inclusion, and systemic reform… [](https://thailandbusinessnews.net/press-release/ritfit-announces-150000-partnership-with-breast-cancer-research-foundation-to-advance-womens-health-through-fitness/) ![RITFIT Announces 0,000 Partnership with Breast Cancer Research Foundation to Advance Women's Health Through Fitness](https://i0.wp.com/mmx.prnasia.com/media/MS1991314/20260917232245EDT_image_1.jpg?resize=260%2C140&ssl=1 "RITFIT Announces 0,000 Partnership with Breast Cancer Research Foundation to Advance Women's Health Through Fitness") ## RITFIT Announces $150,000 Partnership with Breast Cancer Research Foundation to Advance Women's Health Through Fitness CHINO HILLS, Calif., Sept. 20, 2026 /PRNewswire/ — RITFIT, a leading U.S.…